Rating Change
Canaccord Genuity analysts initiated coverage on Eton Pharmaceuticals, Inc. (NASDAQ:ETON) with a Buy rating on July 17, 2026.
new coverageNASDAQ:ETON
Canaccord Genuity Initiates Coverage on Eton Pharmaceuticals, Inc. (ETON) with Buy
Rating Change Canaccord Genuity analysts initiated coverage on Eton Pharmaceuticals, Inc. (NASDAQ:ETON) with a Buy rating on July 17, 2026. Market Context Eton Pharmaceuticals,…
Market Context
Eton Pharmaceuticals, Inc. operates in the Healthcare sector. The stock currently trades at $39.01 with a market capitalization of $453.5M.
Analyst coverage from Canaccord Genuity provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Eton Pharmaceuticals, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Recent Analyst Activity for Eton Pharmaceuticals, Inc.
Among the 10 most recent ratings: 10 Buy, 0 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 17, 2026 | Canaccord Genuity | Buy | N/A |
| May 15, 2026 | HC Wainwright & Co. | Buy | N/A |
| Mar 20, 2026 | Craig-Hallum | Buy | N/A |
| Mar 20, 2026 | HC Wainwright & Co. | Buy | N/A |
| Mar 20, 2026 | B. Riley Securities | Buy | N/A |
Related Tools: Analyst Ratings Dashboard | View ETON Stock Page
Frequently Asked Questions
What does a Buy rating mean for ETON?
A Buy rating from Canaccord Genuity reflects the analyst's outlook on Eton Pharmaceuticals, Inc. (NASDAQ:ETON). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Where can I find more analyst ratings?
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the ETON forecast page.